The Camp Lejeune Justice Act litigation is gaining momentum as a ruling is awaited in the first trial and a second is set to begin next week.
Federal Judge Terrence Boyle has ruled that scientific evidence presented during the first trial can be used in the second, involving Marine Corps veteran David Fancher.
The order allows testimony and exhibits from Frank Mousser's trial to be used in Fancher's case, including evidence about contaminated drinking water at Camp Lejeune and its potential health effects.
Both men developed kidney cancer after being stationed at the Marine Corps base.
The ruling means attorneys won't have to repeat much of the scientific testimony presented during Mousser's trial last week.
They can still introduce evidence specific to Fancher's exposure, illness and damages.
Fancher's trial is scheduled to begin November 9, while a ruling in Mousser's case remains pending.
